Genetic links to myopia in children and adolescents
Official title: Genetic Variants and Their Association With Myopia Risk, Progression, and Optimal Interventions in Children
Run by Beijing Visionly Plus Eye Hospital · NCT07030153 · Data updated 2026-11-12
The team will test whether specific gene variants influence myopia risk and progression in children and adolescents and whether those genes change how well treatments like low‑dose atropine drops, orthokeratology lenses, specialty glasses, or more outdoor time work.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 18 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Beijing Visionly Plus Eye Hospital Academic / other |
| Locations | 2 sites (Beijing and 1 other locations) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | August 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | June 22, 2025 |
| Trial ID | NCT07030153 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and adolescents aged 6–18 with any spherical equivalent refraction whose parents or guardians consent to genetic testing and who do not have suspected genetic syndromes, other eye diseases, or prior refractive surgery are ideal candidates.
✕Probably not a fit
Patients with known genetic syndromes affecting the eye, other ocular diseases (for example glaucoma, cataracts, or retinal abnormalities), prior refractive surgery, or adults outside the 6–18 age range are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will collect DNA via oral swab from participants aged 6–18 and analyze myopia-related gene variants. Researchers will link genetic data to clinical measures such as spherical equivalent refraction and axial length change, and they will record participants' use of common myopia control measures (low-dose atropine, orthokeratology, specialized lenses, and time outdoors). The team will model gene-by-treatment interactions to see whether genetic profiles modify treatment response and disease progression. Finally, investigators will develop a genetic risk score intended to support personalized myopia prevention and treatment strategies.
Why it matters
Potential benefit: If successful, this work could allow prediction of which children are at higher risk and help match them to the most effective preventive or treatment strategies.
How similar studies have gone: Previous research has identified genetic variants and polygenic risk scores associated with myopia risk, but evidence for consistent gene-by-treatment interactions and routine clinical use remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 6-18 years. * Any Spherical equivalent refraction (SER) * Parental consent for genetic testing. Exclusion Criteria: * Suspected genetic syndromes (e.g., Stickler, Marfan). * Other eye diseases (e.g., glaucoma, cataracts, retinal abnormalities, strabismus). * Prior refractive surgery
Where it's running
-
Beijing New Vision Eye Hospital
Beijing, China Recruiting -
Beijing Visionly Plus Eye Hospital
Beijing, China Recruiting
Study contacts
- Study coordinator: Lin Yang, M.D.
- Email: roc001cn@gmail.com
- Phone: +86-17898805125
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
-
Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia
This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.
-
Seeing clearly in low light after Ray-Tracing guided LASIK
A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.